18-12999434-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032142.4(CEP192):āc.10T>Cā(p.Phe4Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000901 in 1,543,238 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_032142.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEP192 | NM_032142.4 | c.10T>C | p.Phe4Leu | missense_variant | 2/45 | ENST00000506447.5 | NP_115518.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEP192 | ENST00000506447.5 | c.10T>C | p.Phe4Leu | missense_variant | 2/45 | 5 | NM_032142.4 | ENSP00000427550.1 | ||
CEP192 | ENST00000589596.5 | c.10T>C | p.Phe4Leu | missense_variant | 2/18 | 2 | ENSP00000466258.1 | |||
CEP192 | ENST00000325971 | c.-1206T>C | 5_prime_UTR_variant | 2/44 | 5 | ENSP00000317156.9 | ||||
CEP192 | ENST00000507064.2 | n.10T>C | non_coding_transcript_exon_variant | 2/5 | 3 | ENSP00000476907.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000204 AC: 3AN: 146720Hom.: 0 AF XY: 0.0000385 AC XY: 3AN XY: 77892
GnomAD4 exome AF: 0.0000971 AC: 135AN: 1391024Hom.: 0 Cov.: 29 AF XY: 0.0000787 AC XY: 54AN XY: 685910
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152214Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 30, 2024 | The c.10T>C (p.F4L) alteration is located in exon 2 (coding exon 1) of the CEP192 gene. This alteration results from a T to C substitution at nucleotide position 10, causing the phenylalanine (F) at amino acid position 4 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at